TITLE

Cutting costs on mono-resistant tuberculosis diagnosis could eventually end up being more expensive

AUTHOR(S)
Rouzaud, F.; Robledo, J.
PUB. DATE
October 2010
SOURCE
Indian Journal of Medical Microbiology;Oct2010, Vol. 28 Issue 4, p412
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Combined drug medium with isoniazid and rifampicin for identification of mutli-drug resistant Mycobacterium tuberculosis," by S. Nalini and colleagues.
ACCESSION #
55249715

 

Related Articles

  • Comparision of Performance Characteristics of Automated PCR Systems with Culture for Detection of MTB Complex from Clinical Samples in Central India. Desikan, P.; De, S.; Mishra, P.; Jain, A.; Panwalkar, N.; Verma, M.; Maudar, K. K. // Indian Journal of Medical Microbiology;Jul2009, Vol. 27 Issue 3, p277 

    A letter to the editor is presented about the different performance characteristics of automated COBAS AMPLICOR (CA) system and real time polymerase chain reaction (RT-PCR) for detection of mycobacterium tuberculosis in India.

  • Vaccination against bovine TB with Mycobacterium microti. Jones, Trevor // Veterinary Record: Journal of the British Veterinary Association;2/13/2010, Vol. 166 Issue 7, p214 

    A letter to the editor is presented in response to the article regarding the evidences from the comprehensive records that consumption of bovine milk with Mycobacterium bovis could prevent death from Mycobacterium tuberculosis in adult human populations in the previous issue.

  • Caspofungin/rifampicin interaction.  // Reactions Weekly;10/6/2012, Issue 1422, p15 

    The article describes the case of a 65-year-old woman who developed Candida (C.) parapsilosis candidaemia due to failure of treatment with caspofungin for C. lusitaniae while receiving rifampicin for Mycobacterium tuberculosis.

  • Researchers identify 39 genes related to TB drug resistance. Shafer, Emily; Volansky, Rob; Zacharyczuk, Colleen // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p40 

    The article discusses a study published in a 2013 issue of the periodical "Nature Genetics" that reported the identification of 39 new genes associated with drug resistance in Mycobacterium tuberculosis.

  • New, novel treatment of multidrug-resistant Mycobacterium tuberculosis. Boeser, Kimberly D. // Infectious Disease News;Jul2013, Vol. 26 Issue 7, p30 

    The article discusses the use of bedaquiline, a diarylquinoline and antimycobacterial, as a novel treatment of multidrug-resistant Mycobacterium tuberculosis (MDR-TB).

  • Three-in-one drug to tackle stubborn TB. Coghlan, Andy // New Scientist;7/28/2012, Vol. 215 Issue 2875, p13 

    This article reports on the drug PaMZ as a treatment for tuberculosis (TB) highlighting its chemical composition of pyrazinamide mixed with antibiotic moxifloxacin, its effectiveness against resistant strains of Mycobacterium tuberculosis, and its potential for treating TB in HIV-positive people.

  • Rapid TB/MDR-TB test shown effective in resource-limited settings. Cohn, David // Infectious Disease News;May2011, Vol. 24 Issue 5, p41 

    The article discusses a study by Doctor Catharina C. Boehme and colleagues on the effectiveness of a Mycobacterium tuberculosis and rifampin-resistant rapid test in resource-limited settings in South Africa, Peru, India, Azerbaijan and the Philippines.

  • The New White Plague. Walton, David; Farmer, Paul // JAMA: Journal of the American Medical Association;12/6/2000, Vol. 284 Issue 21, p2789 

    Comments on mycobacterium tuberculosis (MDRTB) and on how the disease has increased in prevalence internationally. Resistance of the disease to multiple first-line drugs; Use of the directly observed therapy, short-course (DOTS) and its rates of success; How tuberculosis remains the leading...

  • Mechanisms of control of Mycobacterium tuberculosis by NK cells: role of glutathione. Allen, Michael; Bailey, Cedric; Cahatol, Ian; Dodge, Levi; Yim, Jay; Kassissa, Christine; Luong, Jennifer; Kasko, Sarah; Pandya, Shalin; Venketaraman, Vishwanath // Frontiers in Immunology;Oct2015, Vol. 6, p1 

    Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tb), continues to be one of the most prevalent infectious diseases in the world. There is an upward trend in occurrence due to emerging multidrug resistant strains and an increasingly larger proportion of immunocompromised patient...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics